Literature DB >> 31263917

Impact of Obesity on Left Ventricular Thickness in Children with Hypertrophic Cardiomyopathy.

Seshadri Balaji1, Michael P DiLorenzo2, Frank A Fish3, Susan P Etheridge4, Peter F Aziz5, Mark W Russell6, Svjetlana Tisma7, Andreas Pflaumer8, Narayanswami Sreeram9, Peter Kubus10, Ian H Law11, Michal J Kantoch12, Naomi J Kertesz13, Margaret Strieper14, Christopher C Erickson15, Jeremy P Moore16, Stephanie J Nakano17, Harinder R Singh18,19, Philip Chang20, Mitchell Cohen21, Anne Fournier22, Maria V Ilina23, Richard T Smith24, Frank Zimmerman25, Michaela Horndasch26, Walter Li27, Anjan Batra28, Leonardo Liberman29, Robert Hamilton30, Christopher M Janson31, Shubhayan Sanatani32, Ilana Zeltser33, George McDaniel34, Andrew D Blaufox35, Jason M Garnreiter36, Hannah Katcoff2, Maully Shah2.   

Abstract

Obesity is associated with additional left ventricular hypertrophy (LVH) in adults with hypertrophic cardiomyopathy (HCM). It is not known whether obesity can lead to further LVH in children with HCM. Echocardiographic LV dimensions were determined in 504 children with HCM. Measurements of interventricular septal thickness (IVST) and posterior wall thickness (PWT), and patients' weight and height were recorded. Obesity was defined as a body mass index (BMI) ≥ 99th percentile for age and sex. IVST data was available for 498 and PWT data for 484 patients. Patient age ranged from 2 to 20 years (mean ± SD, 12.5 ± 3.9) and 340 (68%) were males. Overall, patient BMI ranged from 7 to 50 (22.7 ± 6.1). Obesity (BMI 18-50, mean 29.1) was present in 140 children aged 2-19.6 (11.3 ± 4.1). The overall mean IVST was 20.5 ± 9.6 mm and the overall mean PWT was 11.0 ± 8.4 mm. The mean IVST in the obese patients was 21.6 ± 10.0 mm and mean PWT was 13.3 ± 14.7 mm. The mean IVST in the non-obese patients was 20.1 ± 9.5 mm and mean PWT was 10.4 ± 4.3 mm. Obesity was not significantly associated with IVST (p = 0.12), but was associated with increased PWT (0.0011). Obesity is associated with increased PWT but not IVST in children with HCM. Whether obesity and its impact on LVH influences clinical outcomes in children with HCM needs to be studied.

Entities:  

Keywords:  Defibrillator; Hypertrophic cardiomyopathy; Obesity; Sudden death

Mesh:

Year:  2019        PMID: 31263917     DOI: 10.1007/s00246-019-02145-9

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  5 in total

Review 1.  Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications.

Authors:  Jun Ren; Ne N Wu; Shuyi Wang; James R Sowers; Yingmei Zhang
Journal:  Physiol Rev       Date:  2021-05-05       Impact factor: 37.312

2.  Discordant clinical features of identical hypertrophic cardiomyopathy twins.

Authors:  Giuliana G Repetti; Yuri Kim; Alexandre C Pereira; Jodie Ingles; Mark W Russell; Neal K Lakdawala; Carolyn Y Ho; Sharlene Day; Christopher Semsarian; Barbara McDonough; Steven R DePalma; Daniel Quiat; Eric M Green; Christine E Seidman; J G Seidman
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-09       Impact factor: 12.779

Review 3.  TGF-β: The missing link in obesity-associated airway diseases?

Authors:  Joanna Woo; Cynthia Koziol-White; Reynold Panettieri; Joseph Jude
Journal:  Curr Res Pharmacol Drug Discov       Date:  2021-02-05

Review 4.  Unraveling the Genotype-Phenotype Relationship in Hypertrophic Cardiomyopathy: Obesity-Related Cardiac Defects as a Major Disease Modifier.

Authors:  Edgar E Nollet; B Daan Westenbrink; Rudolf A de Boer; Diederik W D Kuster; Jolanda van der Velden
Journal:  J Am Heart Assoc       Date:  2020-11-11       Impact factor: 6.106

Review 5.  Sex Differences in Hypertrophic Cardiomyopathy: Interaction With Genetics and Environment.

Authors:  Alexandra Butters; Neal K Lakdawala; Jodie Ingles
Journal:  Curr Heart Fail Rep       Date:  2021-09-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.